Domain Associates API Closes on $28M Round Supporting Development of Colorectal Test, Biomarker Discovery Efforts Premium Applied Proteomics said this week that it has closed a $28 million Series C financing round. GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic Premium In March 2010, Austin, Texas-based diagnostics firm Vermillion launched sales of its OVA1 ovarian cancer test. Epic Sciences Raises $13M in Series B Round NEW YORK (GenomeWeb News) – Epic Sciences today announced it has completed its Series B financing round raising $13 million. Astute Medical Completes $40M Series C Funding Round Premium Protein biomarker diagnostics firm Astute Medical this week said it had completed a Series C financing round that raised $40.4 million. Applied Proteomics Snags $22.5M in Funding; Aims to Optimize Mass Spec-Based Biomarker Discovery Premium By Adam Bonislawski Feb 10, 2012 People in the News: New Board Member, CEO at Applied Proteomics Premium Mar 11, 2011 Astute Medical Raises $13M for Protein Biomarker Dx Development Premium Nov 12, 2009 Microchip Biotechnologies Reels in $18.1M in Financing Breaking News Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates Veracyte Q2 Revenues More Than Double on Test Volume Spike Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent Qiagen Q2 Revenues Grow 28 Percent CareDx Q2 Revenues Up 77 Percent Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds The Scan Booster Push New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high. With Help from Mr. Fluffington, PurrhD Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic. Man Charged With Threatening to Harm Fauci, Collins The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials. Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.